Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
AIM ImmunoTech Inc. (AIM) had Debt to Capital Ratio of 0.05 for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
$0.04M |
|
$-3.70M |
|
$0.01M |
|
$0.03M |
|
$4.52M |
|
$-4.49M |
|
$0.79M |
|
$-3.70M |
|
$-3.97M |
|
$-3.70M |
|
$-3.70M |
|
$-3.70M |
|
$-3.97M |
|
$-4.49M |
|
$-4.42M |
|
57.68M |
|
57.68M |
|
$-0.06 |
|
$-0.06 |
|
| Balance Sheet Financials | |
$7.57M |
|
$0.12M |
|
$6.02M |
|
$13.59M |
|
$10.10M |
|
$0.14M |
|
$0.58M |
|
$10.68M |
|
$2.91M |
|
$0.38M |
|
$2.91M |
|
58.67M |
|
| Cash Flow Statement Financials | |
$-10.93M |
|
$1.00M |
|
$5.41M |
|
$5.44M |
|
$0.92M |
|
$-4.52M |
|
$0.49M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.75 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.05 |
0.94 |
|
77.14% |
|
-12825.72% |
|
-12825.72% |
|
-- |
|
-10571.43% |
|
-10571.43% |
|
$-10.95M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-127.06% |
|
-973.68% |
|
-27.23% |
|
-121.27% |
|
$0.05 |
|
$-0.19 |
|
$-0.19 |
|